-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
NKGen Biotech, Inc. quarterly and annual Depreciation history and change rate from Q3 2022 to Q4 2024.
- NKGen Biotech, Inc. Depreciation for the quarter ending 31 Dec 2024 was $300,000.
- NKGen Biotech, Inc. Depreciation for the twelve months ending 31 Dec 2024 was $1,200,000, a 9.09% increase year-over-year.
- NKGen Biotech, Inc. annual Depreciation for 2024 was $1,200,000, a 9.09% increase from 2023.
- NKGen Biotech, Inc. annual Depreciation for 2023 was $1,100,000, a 8.33% decline from 2022.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)